Inflammasome Therapeutics is a science based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and Parkinson's disease.
View Top Employees from Inflammasome Therapeutics| Website | http://www.inflam.com |
| Revenue | $1 million |
| Employees | 5 (4 on RocketReach) |
| Address | 57 Chapel Street Suite 100, Newton, Massachusetts 02458, US |
| Phone | (617) 331-1071 |
| Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
| Competitors | ARKAY Therapeutics, Cirius Therapeutics, EIP PHARMA, INC, MetiMedi Co., Ltd., Vascular Pharmaceuticals |
| SIC | SIC Code 804 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 62139 Companies, NAICS Code 621399 Companies, NAICS Code 6213 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular Inflammasome Therapeutics employee's phone or email?
Inflammasome Therapeutics Questions
The Inflammasome Therapeutics annual revenue was $1 million in 2024.
Marty Nazzaro is the Vice President Operations of Inflammasome Therapeutics.
4 people are employed at Inflammasome Therapeutics.
Inflammasome Therapeutics is based in Newton, Massachusetts.
The NAICS codes for Inflammasome Therapeutics are [62139, 621399, 6213, 621, 62].
The SIC codes for Inflammasome Therapeutics are [804, 80].
Top Inflammasome Therapeutics Employees
-
45+
-
53
-
5+5+
Related Companies
